Neogenomics Inc (NEO)

EBITDA Margin

1.68%

TTM · Period ending:

NEO logo

NEO EBITDA Margin

Latest reported1.68%
NEO TTM EBITDA Margin (-237.07% → 1.68%)
High-resolution chart · PNG

NEO ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Neogenomics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
1.6816%
-4.4975%
-5.4025%
-5.6684%
-4.1307%
-0.0138%
-0.2287%
-0.0682%
-0.6128%
-1.8347%
-2.976%
-5.3377%
-9.2625%
-12.2661%
-15.7131%
-19.6095%
-16.4694%
5.5202%
9.342%
18.6282%
22.3365%
3.1343%
6.4514%
4.6288%
4.1884%
8.5961%
9.2041%
9.525%
10.0706%
9.4971%
11.4696%
12.2336%
10.2701%
10.9043%
10.0018%
7.6288%
9.2964%
9.4999%
10.5636%
11.3206%
10.4812%
9.2381%
6.2053%
7.8505%
7.6151%
8.0239%
9.025%
9.1663%
10.9305%
11.3564%
11.4117%
10.4572%
7.6678%
7.8805%
8.402%
8.0652%
8.9371%
7.0708%
3.8566%
1.5808%
-1.3448%
-3.5359%
-3.4389%
-6.3445%
-5.8805%
-3.5629%
-1.8409%
-0.1504%
1.5421%
1.2967%
-0.718%
-5.8787%
-10.7444%
-19.7754%
-23.7549%
-16.964%
-10.8091%
0.0794%
5.6935%
7.1874%
2.274%
-7.5757%
-32.8356%
-46.6882%
-75.0951%
-107.1541%
-112.1715%
-88.5814%
-91.9243%
-100.5802%
-120.581%
390.9346%
448.9774%
873.8666%
1,545.6825%
-19,940.3791%
-74,062.8638%
-752,696.5%
-778,819.6%
-100,419.6%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.